Harmesh Aojula

Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr–abl fusion gene in Chronic Myeloid Leukemia cells

Yamini Arthanari, Alain Pluen, Ramkumar Rajendran et al. · Journal of Controlled Release · 2010 · 77 citations · Full text

Hematological Malignancy, Tumor Biology, Bcr–abl Fusion Gene +7

Characterization of haem disorder by circular dichroism

Harmesh Aojula, Michael T. Wilson, A.F. Drake · Biochemical Journal · 1986 · 56 citations · Full text

Comparative C.d, Reconstituted Myoglobin, Signal Transduction +14

Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity

Leonidas Gkionis, Richard A. Campbell, Harmesh Aojula et al. · International Journal of Pharmaceutics · 2020 · 53 citations · Full text

Lipid Preparation, Nanomedicine, Drug Targeting +11

Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics

Leonidas Gkionis, Harmesh Aojula, Lynda K. Harris et al. · International Journal of Pharmaceutics · 2021 · 52 citations · Full text

Improved Tat-mediated plasmid DNA transfer by fusion to LK15 peptide

Amer F. Saleh, Harmesh Aojula, Yamini Arthanari et al. · Journal of Controlled Release · 2010 · 51 citations · Full text

Protein Expression, Natural Sciences, Dna Replication +9